Search

everythinglearnresearchcommunity

for

Search:↓

CARASIL, a rare genetic disorder, was confirmed in an Arabic woman, highlighting its rarity and need for stroke prevention.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Mice with autoimmune hair loss showed signs of heart problems.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

The AR gene is linked to male-pattern baldness, TNFSF4 to heart disease, SLC19A3 to BBGD, MCT8 to a syndrome, and segmental duplications to genetic variation.

Orai1 protein is crucial for tooth development and affects enamel thickness and mineralization.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Different types of male pattern baldness have unique inflammation-related protein patterns.

Androgens can affect glucocorticoid signaling in specific mouse brain areas.

Androgen receptors in the brain affect metabolism and reproduction differently in males and females, and may help manage PCOS symptoms in females.

A gene mutation in Lama3 is linked to a common type of hair loss.

Disrupting the Hars2 gene in mice causes hearing loss due to mitochondrial problems and hair cell damage.

CT60 polymorphism might increase the risk of Alopecia Areata.

Silencing certain circadian clock genes increases skin pigmentation.

Sesamin may help treat hair loss by affecting specific cell pathways.

Cardamonin reduces inflammation in gum tissue cells.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Adults with Beta Thalassemia Major are more likely to have skin, hair, and nail disorders.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Atopy and altered T cell functions contribute to Alopecia Areata.

Higher IL-17A levels indicate more severe alopecia areata.

SQSTM1 is linked to increased risk of alopecia areata.